» Articles » PMID: 39677689

Structural Basis for Aminoacylation of Cellular Modified TRNA by Human Lysyl-tRNA Synthetase

Overview
Journal bioRxiv
Date 2024 Dec 16
PMID 39677689
Authors
Affiliations
Soon will be listed here.
Abstract

The average eukaryotic tRNA contains 13 posttranscriptional modifications; however, their functional impact is largely unknown. Our understanding of the complex tRNA aminoacylation machinery in metazoans also remains limited. Herein, using a series of high-resolution cryo-electron microscopy (cryo-EM) structures, we provide the mechanistic basis for recognition and aminoacylation of fully-modified cellular tRNA by human lysyl-tRNA synthetase (h-LysRS). The tRNA anticodon loop modifications S34 (mcmsU) and R37 (mstA) play an integral role in recognition by h-LysRS. Modifications in the T-, variable-, and D-loops of tRNA are critical for ordering the metazoan-specific N-terminal domain of LysRS. The two catalytic steps of tRNA aminoacylation are structurally ordered; docking of the 3'-CCA end in the active site cannot proceed until the lysyl-adenylate intermediate is formed and the pyrophosphate byproduct is released. Association of the h-LysRS-tRNA complex with a multi-tRNA synthetase complex-derived peptide shifts the equilibrium towards the 3'-CCA end 'docked' conformation and allosterically enhances h-LysRS catalytic efficiency. The insights presented here have broad implications for understanding the role of tRNA modifications in protein synthesis, the human aminoacylation machinery, and the growing catalog of metabolic and neurological diseases linked to it.

References
1.
Wu S, Zheng L, Hei Z, Zhou J, Li G, Li P . Human lysyl-tRNA synthetase evolves a dynamic structure that can be stabilized by forming complex. Cell Mol Life Sci. 2022; 79(2):128. PMC: 11072160. DOI: 10.1007/s00018-022-04158-9. View

2.
Burgess R, Storkebaum E . tRNA Dysregulation in Neurodevelopmental and Neurodegenerative Diseases. Annu Rev Cell Dev Biol. 2023; 39:223-252. DOI: 10.1146/annurev-cellbio-021623-124009. View

3.
Cavarelli J, Eriani G, Rees B, Ruff M, Boeglin M, Mitschler A . The active site of yeast aspartyl-tRNA synthetase: structural and functional aspects of the aminoacylation reaction. EMBO J. 1994; 13(2):327-37. PMC: 394812. DOI: 10.1002/j.1460-2075.1994.tb06265.x. View

4.
Emsley P, Lohkamp B, Scott W, Cowtan K . Features and development of Coot. Acta Crystallogr D Biol Crystallogr. 2010; 66(Pt 4):486-501. PMC: 2852313. DOI: 10.1107/S0907444910007493. View

5.
Hyeon D, Kim J, Ahn T, Cho Y, Hwang D, Kim S . Evolution of the multi-tRNA synthetase complex and its role in cancer. J Biol Chem. 2019; 294(14):5340-5351. PMC: 6462501. DOI: 10.1074/jbc.REV118.002958. View